A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis. - King's College London (ClinicalTrials.gov, 2019)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com